Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

Hospital Universiti Sains Malaysia

Status: Not yet enrolling

Conditions: End Stage Renal Failure

Treatments: Drug: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

Study type: Interventional

Funder types: Other

Identifiers

NCT06389617

USM/JEPeM/KK/24010061

Details and patient eligibility

About

To compare the analgesic properties of ultrasound guided supraclavicular block using ropivacaine 0.5% in arteriovenous fistula creation when used in combination with intravenous administered dexamethasone at 4mg and 8 mg as an adjuvant

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Adult, age 18 to 65 years End stage renal disease patients for AV fistula creation

Exclusion criteria

Not suitable candidate as determined by the primary team Refusal for brachial plexus block History of allergy to dexamethasone or local anesthesia Pregnancy History of previous brachial plexus injury Coagulopathy Local skin site infection Known neuropathy involving the arm undergoing surgery Patients with glucose reading more then 12mmol/

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

50 participants in 2 patient groups

GROUP DF

Active Comparator group

Description:

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous dexamethasone 4mg

Treatment:

Drug: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone

GROUP DE

Active Comparator group

Description:

supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous dexamethasone 8mg

Treatment:

Drug: supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone